JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB50036

Recombinant human TGF beta 1 protein (Active)

Recombinant human TGF beta 1 protein (Active)

Be the first to review this product! Submit a review

|

(78 Publications)

Recombinant human TGF beta 1 protein (Active) is a Human Full Length TGF-beta 1 protein, in the 279 to 390 aa range with >98% purity, < 1 EU/µg endotoxin level and suitable for Cell Culture, Functional studies, western blot, HPLC and SDS-PAGE. The predicted molecular weight of ab50036 recombinant protein is 25 kDa.

- Save time and ensure accurate results - using our recombinant TGF-beta 1 cytokine protein
- Optimal protein bioactivity, stability and reproducibility
- Available in different sizes to fit your experimental needs
- Cited in over 60 publications

查看别名

TGFB, TGFB1, Transforming growth factor beta-1 proprotein

关键信息

纯度

>98% SDS-PAGE

内毒素水平

< 1 EU/µg

表达系统

HEK 293 cells

标签

Tag free

应用

FuncS, WB, Cell Culture, HPLC, SDS-PAGE

applications

生物活性

Yes

生物学活性

The ED50, as determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells, is ≤ 0.05 ng/ml), corresponding to a specific activity of ≥ 2 x 107 units/mg.

访问

P01137

不含动物源

No

不含载体蛋白

No

种属

Human

复溶

reconstitute with 10 mM citric acid, pH 3.0 at 1mg/mL

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Cell Culture": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "HPLC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>ab50036 can be used as a WB positive control in conjunction with <a href='/products/unavailable/tgf-beta-1-antibody-ab46780'>ab46780</a>.</p>" } } }

产品详情

Ensure the validity of your result using our Recombinant TGF beta 1 protein ab50036 as a control. ab50036 can be used as a positive control in SDS-PAGE and western blot assays.

Check out our Western blot protocol for more information here

TGF-beta is secreted predominantly as latent complexes which are stored at the cell surface and in the extracellular matrix.

The release of biologically active TGF-β isoform from a latent complex involves proteolytic processing of the complex and/or induction of conformational changes by proteins such as thrombospondin-1.

TGF-β1 is the most abundant isoform secreted by almost every cell type.

序列信息

[{"sequence":"ALDTNYCFSSTEKNCCVRQLYIDFRKDLGWKWIHEPKGYHANFCLGPCPYIWSLDTQYSKVLALYNQHNPGASAAPCCVPQALEPLPIVYYVGRKPKVEQLSNMIVRSCKCS","proteinLength":"Full Length","predictedMolecularWeight":"25 kDa","actualMolecularWeight":null,"aminoAcidEnd":390,"aminoAcidStart":279,"nature":"Recombinant","expressionSystem":"HEK 293 cells","accessionNumber":"P01137","tags":[]}]

性能和储存信息

运输条件
Blue Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle
True

特殊说明

形式

Lyophilized

附加说明

> 98% by HPLC analyses. Endotoxin Level: < 0.1 ng/µg of protein (< 1 EU/µg).

常规信息

功能

Transforming growth factor beta-1 proprotein : Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively.. Latency-associated peptide. Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed : 28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed : 19651619, PubMed : 19750484, PubMed : 2022183, PubMed : 22278742, PubMed : 8617200, PubMed : 8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed : 19651619, PubMed : 19750484, PubMed : 22278742). Interaction with integrins (ITGAV : ITGB6 or ITGAV : ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed : 22278742, PubMed : 28117447).. Transforming growth factor beta-1. Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps : following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed : 29109152). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed : 19651619, PubMed : 19750484, PubMed : 2022183, PubMed : 22278742, PubMed : 8617200, PubMed : 8939931). TGF-beta-1 is released from LAP by integrins (ITGAV : ITGB6 or ITGAV : ITGB8) : integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed : 22278742, PubMed : 28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed : 20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and 'milieu molecules' (By similarity). Plays an important role in bone remodeling : acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed : 25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed : 25893292, PubMed : 29483653, PubMed : 30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed : 25893292, PubMed : 30696809).

序列相似性

Belongs to the TGF-beta family.

翻译后修饰

Transforming growth factor beta-1 proprotein: The precursor proprotein is cleaved in the Golgi apparatus by FURIN to form Transforming growth factor beta-1 (TGF-beta-1) and Latency-associated peptide (LAP) chains, which remain non-covalently linked, rendering TGF-beta-1 inactive.. Latency-associated peptide. N-glycosylated (PubMed:2493139, PubMed:28117447, PubMed:3162913). Deglycosylation leads to activation of Transforming growth factor beta-1 (TGF-beta-1); mechanisms triggering deglycosylation-driven activation of TGF-beta-1 are however unclear (PubMed:2493139).

产品实验方案

靶点信息

Transforming growth factor beta-1 proprotein : Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively.. Latency-associated peptide. Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed : 28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed : 19651619, PubMed : 19750484, PubMed : 2022183, PubMed : 22278742, PubMed : 8617200, PubMed : 8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed : 19651619, PubMed : 19750484, PubMed : 22278742). Interaction with integrins (ITGAV : ITGB6 or ITGAV : ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed : 22278742, PubMed : 28117447).. Transforming growth factor beta-1. Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps : following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed : 29109152). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed : 19651619, PubMed : 19750484, PubMed : 2022183, PubMed : 22278742, PubMed : 8617200, PubMed : 8939931). TGF-beta-1 is released from LAP by integrins (ITGAV : ITGB6 or ITGAV : ITGB8) : integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed : 22278742, PubMed : 28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed : 20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and 'milieu molecules' (By similarity). Plays an important role in bone remodeling : acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed : 25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed : 25893292, PubMed : 29483653, PubMed : 30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed : 25893292, PubMed : 30696809).
See full target information TGFB1

文献 (78)

Recent publications for all applications. Explore the full list and refine your search

International journal of ophthalmology 18:779-791 PubMed40385123

2025

Nintedanib regulates miR-23b-3p/TGFBR2 axis and competitively binds to TGFBR2 protein, inhibiting EMT process in human pterygium cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ke-Ke Zhang,Meng Li,Yan-Hong Liao,Xiao-Tian Liu,Yong-Bo Bao,Yan Gong

International journal of molecular sciences 26: PubMed40244247

2025

Anti-Fibrotic Effect of Oleamide Identified from the Lam. Leaves via Inhibition of TGF-β1-Induced SMAD2/3 Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chavisa Khongpiroon,Watunyoo Buakaew,Paul J Brindley,Saranyapin Potikanond,Krai Daowtak,Yordhathai Thongsri,Pachuen Potup,Kanchana Usuwanthim

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39:e70427 PubMed40022609

2025

Insulin receptor responsiveness governs TGFβ-induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Wang-Hsin Lee,Evelyn A Bates,Zachary A Kipp,Sally N Pauss,Genesee J Martinez,Cheavar A Blair,Terry D Hinds

BMC pharmacology & toxicology 26:17 PubMed39871379

2025

Analysis of the potential biological mechanisms of geniposide on renal fibrosis by network pharmacology and experimental verification.

Applications

Unspecified application

Species

Unspecified reactive species

Mengqian Liu,Wenman Zhao,Rui Shi,Zhijuan Wang,Xunliang Li,Deguang Wang

Frontiers in neuroscience 18:1504047 PubMed39840011

2025

High spatial resolution gene expression profiling and characterization of neuroblasts migrating in the peri-injured cortex using photo-isolation chemistry.

Applications

Unspecified application

Species

Unspecified reactive species

Takuya Miyamoto,Kazuya Kuboyama,Mizuki Honda,Yasuyuki Ohkawa,Shinya Oki,Kazunobu Sawamoto

International journal of fertility & sterility 19:64-69 PubMed39827393

2025

Effect of Exogenous of Transforming Growth Factor-β1 on Pregnancy Outcome in Mice with Recurrent Pregnancy Loss by Persistent Enhancement of Placental Tissue Indoleamine 2,3-Dioxygenase Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Xinghui Wen,Xiaojuan Chen,Mei Li,Jinnian Zhou,Shouli Dao,Shixiang Li,Hui Cheng,Shuyun Zhao,Guanyou Huang

Cancers 16: PubMed39518142

2024

TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness.

Applications

Unspecified application

Species

Unspecified reactive species

Noemi di Miceli,Chiara Baioni,Linda Barbieri,Davide Danielli,Emiliano Sala,Lucia Salvioni,Stefania Garbujo,Miriam Colombo,Davide Prosperi,Metello Innocenti,Luisa Fiandra

Scientific data 11:868 PubMed39127790

2024

An image-based screen for secreted proteins involved in breast cancer G0 cell cycle arrest.

Applications

Unspecified application

Species

Unspecified reactive species

William A Weston,Jordan A Holt,Anna J Wiecek,James Pilling,Lovisa Holmberg Schiavone,David M Smith,Maria Secrier,Alexis R Barr

Journal for immunotherapy of cancer 12: PubMed38964786

2024

Hypoxia inhibits the iMo/cDC2/CD8+ TRMs immune axis in the tumor microenvironment of human esophageal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chuanqiang Wu,Huan Yu,Fuxiang Liang,Xiancong Huang,Bin Jiang,Zhiling Lou,Yafei Liu,Zixiang Wu,Qi Wang,Hong Shen,Ming Chen,Pin Wu,Ming Wu

International journal of molecular sciences 25: PubMed38892298

2024

Targeted Antisense Oligonucleotide-Mediated Skipping of Murine Exon 17 Partially Addresses Fibrosis in D2. Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica Trundle,Ngoc Lu-Nguyen,Alberto Malerba,Linda Popplewell
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com